カテゴリー： Market Monitor Global, 世界, 医療/バイオ

シンチリマブの世界市場見通し2023年-2029年

◆英語タイトル：Sintilimab Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8662 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：71 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Sintilimab Market 調査レポートは次の情報を含め、グローバルにおけるのシンチリマブ市場規模と予測を収録しています。・世界のシンチリマブ市場：売上、2018年-2023年、2024年-2029年
・世界のシンチリマブ市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のシンチリマブ市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「10ml」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

シンチリマブのグローバル主要企業は、Innovent、 Eli Lilly and Companyなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、シンチリマブのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のシンチリマブ市場：タイプ別、2018年-2023年、2024年-2029年
世界のシンチリマブ市場：タイプ別市場シェア、2022年
・10ml、その他

世界のシンチリマブ市場：用途別、2018年-2023年、2024年-2029年
世界のシンチリマブ市場：用途別市場シェア、2022年
・大人、高齢者、子供

世界のシンチリマブ市場：地域・国別、2018年-2023年、2024年-2029年
世界のシンチリマブ市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるシンチリマブのグローバル売上、2018年-2023年
・主要企業におけるシンチリマブのグローバル売上シェア、2022年
・主要企業におけるシンチリマブのグローバル販売量、2018年-2023年
・主要企業におけるシンチリマブのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Innovent、 Eli Lilly and Company

*************************************************************

・調査・分析レポートの概要
シンチリマブ市場の定義
市場セグメント
世界のシンチリマブ市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のシンチリマブ市場規模
世界のシンチリマブ市場規模：2022年 VS 2029年
世界のシンチリマブ市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのシンチリマブの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のシンチリマブ製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：10ml、その他
シンチリマブのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：大人、高齢者、子供
シンチリマブの用途別グローバル売上・予測

・地域別市場分析
地域別シンチリマブ市場規模 2022年と2029年
地域別シンチリマブ売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Innovent、 Eli Lilly and Company
...

Sintilimab, sold under the brand Tyvyt among others, is a medication used to treat Hodgkin’s disease, and has been approved in China
This report aims to provide a comprehensive presentation of the global market for Sintilimab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sintilimab. This report contains market size and forecasts of Sintilimab in global, including the following market information:
Global Sintilimab Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Sintilimab Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Sintilimab companies in 2022 (%)
The global Sintilimab market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
10 ml Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Sintilimab include Innovent and Eli Lilly and Company etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sintilimab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sintilimab Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Sintilimab Market Segment Percentages, by Type, 2022 (%)
10 ml
Others
Global Sintilimab Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Sintilimab Market Segment Percentages, by Application, 2022 (%)
Adult
Senior Person
Children
Global Sintilimab Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Sintilimab Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sintilimab revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Sintilimab revenues share in global market, 2022 (%)
Key companies Sintilimab sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Sintilimab sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Innovent
Eli Lilly and Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Sintilimab, market overview.
Chapter 2: Global Sintilimab market size in revenue and volume.
Chapter 3: Detailed analysis of Sintilimab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sintilimab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Sintilimab capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Sintilimab Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sintilimab Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sintilimab Overall Market Size
2.1 Global Sintilimab Market Size: 2022 VS 2029
2.2 Global Sintilimab Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Sintilimab Sales: 2018-2029
3 Company Landscape
3.1 Top Sintilimab Players in Global Market
3.2 Top Global Sintilimab Companies Ranked by Revenue
3.3 Global Sintilimab Revenue by Companies
3.4 Global Sintilimab Sales by Companies
3.5 Global Sintilimab Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Sintilimab Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Sintilimab Product Type
3.8 Tier 1, Tier 2 and Tier 3 Sintilimab Players in Global Market
3.8.1 List of Global Tier 1 Sintilimab Companies
3.8.2 List of Global Tier 2 and Tier 3 Sintilimab Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Sintilimab Market Size Markets, 2022 & 2029
4.1.2 10 ml
4.1.3 Others
4.2 By Type – Global Sintilimab Revenue & Forecasts
4.2.1 By Type – Global Sintilimab Revenue, 2018-2023
4.2.2 By Type – Global Sintilimab Revenue, 2024-2029
4.2.3 By Type – Global Sintilimab Revenue Market Share, 2018-2029
4.3 By Type – Global Sintilimab Sales & Forecasts
4.3.1 By Type – Global Sintilimab Sales, 2018-2023
4.3.2 By Type – Global Sintilimab Sales, 2024-2029
4.3.3 By Type – Global Sintilimab Sales Market Share, 2018-2029
4.4 By Type – Global Sintilimab Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Sintilimab Market Size, 2022 & 2029
5.1.2 Adult
5.1.3 Senior Person
5.1.4 Children
5.2 By Application – Global Sintilimab Revenue & Forecasts
5.2.1 By Application – Global Sintilimab Revenue, 2018-2023
5.2.2 By Application – Global Sintilimab Revenue, 2024-2029
5.2.3 By Application – Global Sintilimab Revenue Market Share, 2018-2029
5.3 By Application – Global Sintilimab Sales & Forecasts
5.3.1 By Application – Global Sintilimab Sales, 2018-2023
5.3.2 By Application – Global Sintilimab Sales, 2024-2029
5.3.3 By Application – Global Sintilimab Sales Market Share, 2018-2029
5.4 By Application – Global Sintilimab Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Sintilimab Market Size, 2022 & 2029
6.2 By Region – Global Sintilimab Revenue & Forecasts
6.2.1 By Region – Global Sintilimab Revenue, 2018-2023
6.2.2 By Region – Global Sintilimab Revenue, 2024-2029
6.2.3 By Region – Global Sintilimab Revenue Market Share, 2018-2029
6.3 By Region – Global Sintilimab Sales & Forecasts
6.3.1 By Region – Global Sintilimab Sales, 2018-2023
6.3.2 By Region – Global Sintilimab Sales, 2024-2029
6.3.3 By Region – Global Sintilimab Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Sintilimab Revenue, 2018-2029
6.4.2 By Country – North America Sintilimab Sales, 2018-2029
6.4.3 US Sintilimab Market Size, 2018-2029
6.4.4 Canada Sintilimab Market Size, 2018-2029
6.4.5 Mexico Sintilimab Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Sintilimab Revenue, 2018-2029
6.5.2 By Country – Europe Sintilimab Sales, 2018-2029
6.5.3 Germany Sintilimab Market Size, 2018-2029
6.5.4 France Sintilimab Market Size, 2018-2029
6.5.5 U.K. Sintilimab Market Size, 2018-2029
6.5.6 Italy Sintilimab Market Size, 2018-2029
6.5.7 Russia Sintilimab Market Size, 2018-2029
6.5.8 Nordic Countries Sintilimab Market Size, 2018-2029
6.5.9 Benelux Sintilimab Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Sintilimab Revenue, 2018-2029
6.6.2 By Region – Asia Sintilimab Sales, 2018-2029
6.6.3 China Sintilimab Market Size, 2018-2029
6.6.4 Japan Sintilimab Market Size, 2018-2029
6.6.5 South Korea Sintilimab Market Size, 2018-2029
6.6.6 Southeast Asia Sintilimab Market Size, 2018-2029
6.6.7 India Sintilimab Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Sintilimab Revenue, 2018-2029
6.7.2 By Country – South America Sintilimab Sales, 2018-2029
6.7.3 Brazil Sintilimab Market Size, 2018-2029
6.7.4 Argentina Sintilimab Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Sintilimab Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Sintilimab Sales, 2018-2029
6.8.3 Turkey Sintilimab Market Size, 2018-2029
6.8.4 Israel Sintilimab Market Size, 2018-2029
6.8.5 Saudi Arabia Sintilimab Market Size, 2018-2029
6.8.6 UAE Sintilimab Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Innovent
7.1.1 Innovent Company Summary
7.1.2 Innovent Business Overview
7.1.3 Innovent Sintilimab Major Product Offerings
7.1.4 Innovent Sintilimab Sales and Revenue in Global (2018-2023)
7.1.5 Innovent Key News & Latest Developments
7.2 Eli Lilly and Company
7.2.1 Eli Lilly and Company Company Summary
7.2.2 Eli Lilly and Company Business Overview
7.2.3 Eli Lilly and Company Sintilimab Major Product Offerings
7.2.4 Eli Lilly and Company Sintilimab Sales and Revenue in Global (2018-2023)
7.2.5 Eli Lilly and Company Key News & Latest Developments
8 Global Sintilimab Production Capacity, Analysis
8.1 Global Sintilimab Production Capacity, 2018-2029
8.2 Sintilimab Production Capacity of Key Manufacturers in Global Market
8.3 Global Sintilimab Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Sintilimab Supply Chain Analysis
10.1 Sintilimab Industry Value Chain
10.2 Sintilimab Upstream Market
10.3 Sintilimab Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Sintilimab Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Sintilimab in Global Market
Table 2. Top Sintilimab Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Sintilimab Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Sintilimab Revenue Share by Companies, 2018-2023
Table 5. Global Sintilimab Sales by Companies, (K Units), 2018-2023
Table 6. Global Sintilimab Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Sintilimab Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Sintilimab Product Type
Table 9. List of Global Tier 1 Sintilimab Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sintilimab Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Sintilimab Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Sintilimab Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Sintilimab Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Sintilimab Sales (K Units), 2018-2023
Table 15. By Type - Global Sintilimab Sales (K Units), 2024-2029
Table 16. By Application – Global Sintilimab Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Sintilimab Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Sintilimab Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Sintilimab Sales (K Units), 2018-2023
Table 20. By Application - Global Sintilimab Sales (K Units), 2024-2029
Table 21. By Region – Global Sintilimab Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Sintilimab Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Sintilimab Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Sintilimab Sales (K Units), 2018-2023
Table 25. By Region - Global Sintilimab Sales (K Units), 2024-2029
Table 26. By Country - North America Sintilimab Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Sintilimab Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Sintilimab Sales, (K Units), 2018-2023
Table 29. By Country - North America Sintilimab Sales, (K Units), 2024-2029
Table 30. By Country - Europe Sintilimab Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Sintilimab Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Sintilimab Sales, (K Units), 2018-2023
Table 33. By Country - Europe Sintilimab Sales, (K Units), 2024-2029
Table 34. By Region - Asia Sintilimab Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Sintilimab Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Sintilimab Sales, (K Units), 2018-2023
Table 37. By Region - Asia Sintilimab Sales, (K Units), 2024-2029
Table 38. By Country - South America Sintilimab Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Sintilimab Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Sintilimab Sales, (K Units), 2018-2023
Table 41. By Country - South America Sintilimab Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Sintilimab Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Sintilimab Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Sintilimab Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Sintilimab Sales, (K Units), 2024-2029
Table 46. Innovent Company Summary
Table 47. Innovent Sintilimab Product Offerings
Table 48. Innovent Sintilimab Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Innovent Key News & Latest Developments
Table 50. Eli Lilly and Company Company Summary
Table 51. Eli Lilly and Company Sintilimab Product Offerings
Table 52. Eli Lilly and Company Sintilimab Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Eli Lilly and Company Key News & Latest Developments
Table 54. Sintilimab Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 55. Global Sintilimab Capacity Market Share of Key Manufacturers, 2021-2023
Table 56. Global Sintilimab Production by Region, 2018-2023 (K Units)
Table 57. Global Sintilimab Production by Region, 2024-2029 (K Units)
Table 58. Sintilimab Market Opportunities & Trends in Global Market
Table 59. Sintilimab Market Drivers in Global Market
Table 60. Sintilimab Market Restraints in Global Market
Table 61. Sintilimab Raw Materials
Table 62. Sintilimab Raw Materials Suppliers in Global Market
Table 63. Typical Sintilimab Downstream
Table 64. Sintilimab Downstream Clients in Global Market
Table 65. Sintilimab Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Sintilimab Segment by Type in 2022
Figure 2. Sintilimab Segment by Application in 2022
Figure 3. Global Sintilimab Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Sintilimab Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Sintilimab Revenue, 2018-2029 (US$, Mn)
Figure 7. Sintilimab Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Sintilimab Revenue in 2022
Figure 9. By Type - Global Sintilimab Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Sintilimab Revenue Market Share, 2018-2029
Figure 11. By Type - Global Sintilimab Sales Market Share, 2018-2029
Figure 12. By Type - Global Sintilimab Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Sintilimab Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Sintilimab Revenue Market Share, 2018-2029
Figure 15. By Application - Global Sintilimab Sales Market Share, 2018-2029
Figure 16. By Application - Global Sintilimab Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Sintilimab Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Sintilimab Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Sintilimab Revenue Market Share, 2018-2029
Figure 20. By Region - Global Sintilimab Sales Market Share, 2018-2029
Figure 21. By Country - North America Sintilimab Revenue Market Share, 2018-2029
Figure 22. By Country - North America Sintilimab Sales Market Share, 2018-2029
Figure 23. US Sintilimab Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Sintilimab Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Sintilimab Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Sintilimab Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Sintilimab Sales Market Share, 2018-2029
Figure 28. Germany Sintilimab Revenue, (US$, Mn), 2018-2029
Figure 29. France Sintilimab Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Sintilimab Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Sintilimab Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Sintilimab Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Sintilimab Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Sintilimab Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Sintilimab Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Sintilimab Sales Market Share, 2018-2029
Figure 37. China Sintilimab Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Sintilimab Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Sintilimab Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Sintilimab Revenue, (US$, Mn), 2018-2029
Figure 41. India Sintilimab Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Sintilimab Revenue Market Share, 2018-2029
Figure 43. By Country - South America Sintilimab Sales Market Share, 2018-2029
Figure 44. Brazil Sintilimab Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Sintilimab Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Sintilimab Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Sintilimab Sales Market Share, 2018-2029
Figure 48. Turkey Sintilimab Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Sintilimab Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Sintilimab Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Sintilimab Revenue, (US$, Mn), 2018-2029
Figure 52. Global Sintilimab Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Sintilimab by Region, 2022 VS 2029
Figure 54. Sintilimab Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ シンチリマブの世界市場見通し2023年-2029年(Sintilimab Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

シンチリマブの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp